Showing results (31-40 of 49) with videos related to
Sort By:
Pageof 5
Journal of Drugs in Dermatology : JDD|January 6, 2026
A Novel Topical Agent for the Management of Hyperpigmentation, Including Melasma and Age SpotsXinge Diana Zhang, Claudia Teng, Xuefei Bai, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 25, 2022
Gorlin Syndrome: Assessing Genotype-Phenotype Correlations and Analysis of Early Clinical Characteristics as Risk Factors for Disease SeverityNicolas J Betancourt, Mollie F Qian, Jean R Pickford, et al.Pediatric Blood & Cancer|September 27, 2021
Dermatologic toxicities of targeted antineoplastic agents and immune checkpoint inhibitor therapy in pediatric patients: A systematic reviewLucy Y Liu, Joyce M C Teng, Sheri L Spunt, et al.Pediatric Dermatology|October 14, 2021
Psoriasiform dermatitis during dupilumab treatment for moderate-to-severe atopic dermatitis in childrenJennifer J Parker, Jeffrey L Sugarman, Nanette B Silverberg, et al.JAMA Dermatology|October 17, 2018
Management of Complex Arteriovenous Malformations Using a Novel Combination Therapeutic AlgorithmMalcolm Pyles Chelliah, Huy M Do, Zachary Zinn, et al.Dermatology and Therapy|May 11, 2023
Topical Isotretinoin (TMB-001) Treatment for 12 Weeks Did Not Result in Clinically Relevant Laboratory Abnormalities in Participants with Congenital Ichthyosis in the Phase 2b CONTROL StudyKalyani Marathe, Joyce M C Teng, Scott Guenthner, et al.Clinical and Experimental Dermatology|February 16, 2023
Phase IIb randomized CONTROL study demonstrates a novel topical isotretinoin formulation, TMB-001, is safe and effective in participants with either recessive X-linked or autosomal recessive lamellar congenital ichthyosisDedee F Murrell, Joyce M C Teng, Scott Guenthner, et al.Clinical and Experimental Dermatology|March 17, 2023
Characteristics and outcomes for participants with congenital ichthyosis who responded to treatment with the topical isotretinoin formulation TMB-001: results from the Phase IIb CONTROL studyChristopher G Bunick, Joyce M C Teng, Scott Guenthner, et al.American Journal of Medical Genetics. Part A|March 13, 2016
RASA1 somatic mutation and variable expressivity in capillary malformation/arteriovenous malformation (CM/AVM) syndromeColleen F Macmurdo, Whitney Wooderchak-Donahue, Pinar Bayrak-Toydemir, et al.JAMA Dermatology|July 17, 2014
Dermatologic and dental aspects of the 2012 International Tuberous Sclerosis Complex Consensus StatementsJoyce M C Teng, Edward W Cowen, Mari Wataya-Kaneda, et al.Pageof 5